Abstract
To assess the molecular characterization of disseminated vancomycin-resistant enterococci (VRE) in the intensive care units, 546 enterococci isolates were collected from different clinical samples in a prospective observational study. The results showed that a total number of 33 isolates (6 %) were resistant to vancomycin. Most of the VRE isolates 11 (34 %) were isolated from intensive care units (ICUs). 18 (55 %) VRE isolates were obtained from urinary tract infections. The results from pulsed-field gel electrophoresis showed five common types (CT) and 13 single types (ST) among the VRE isolates. The analysis showed two and one major CTs and ST among the ICUs isolates, respectively. Tn1546 transposon was analyzed using ClaI-digested long PCR (L-PCR) RFLP followed by sequencing. The results showed the presence of two different lineages of transposon among the two clonal groups. Lineage 1 with the arrangement of Tn1546 prototype in the first clonal group and the second lineage with 13 kb harboring two insertion sequences, IS1216 V and IS1542. DNA hybridization showed that vanA gene in all VRE isolates, with an exception of one isolate, was present in the same location on the genome. Overall, the results suggest that a few VRE clonal types were disseminated in ICUs in hospitals in Iran which were able to transfer their vanA with high conjugation frequency.
Similar content being viewed by others
References
Clewell DB (1981) Plasmids, drug resistance, and gene transfer in genus transfer in genus Streptococcus. Microbiol Rev 45:409–436
Clinical and Laboratory Standards Institute (CLSI) (2010) Performance standards for antimicrobial susceptibility testing; 20th informational supplement. CLSI document M100-S20, vol 30. Clinical and Laboratory Standards Institute, Wayne
Clinical and Laboratory Standards Institute (CLSI) (2006) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. CLSI document M7-A7. Clinical and Laboratory Standards Institute, Wayne
Facklam RR, Collins MD (1989) Identification of Enterococcus species isolated from human infections by a conventional test scheme. J Clin Microbiol 27:731–734
Freitas AR, Novais C, Tedim AP, Francia MV, Baquero F, Peixe L, Coque TM (2013) Microevolutionaryeventsinvolvingnarrowhostplasmidsinfluenceslocalfixation of vancomycin-resistance in Enterococcus populations. PLoS ONE 8:e60589
Fridkin SK, Edwards JR, Courval JM, Hill H, Tenover FC, Lawton R, Gaynes RP, McGowan JE Jr, Intensive Care Antimicrobial Resistance Epidemiology (ICARE) Project and the National Nosocomial Infections Surveillance (NNIS) System Hospitals (2001) The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med 135:175–183
Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan JE Jr, Archibald LK, Gaynes RP, Tenover FC (1999) Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis 29:245–252
Fridkin SK, Hill HA, Volkova NV, Edwards JR, Lawton RM, Gaynes RP, McGowan JE Jr, Intensive Care Antimicrobial Resistance Epidemiology Project Hospitals (2002) Temporal changes in prevalence of antimicrobial resistance in 23 U.S. hospitals. Emerg Infect Dis 8:697–701
Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM (1988) CDC definitions for nosocomial infections. Am J Infect Control 16:128–140
Hariharan S, Nanduri SB, Moseley HS, Areti KY, Jonnalagadda R (2003) Spectrum of microbes and antimicrobial resistance in a surgical intensive care unit, Barbados. Am J Infect Control 31:280–287
Huang SS, Rifas-Shiman SL, Pottinger JM, Herwaldt LA, Zembower TR, Noskin GA, Cosgrove SE, Perl TM, Curtis AB, Tokars JL, Diekema DJ, Jernigan JA, Hinrichsen VL, Yokoe DS, Platt R, Centers for Disease Control and Prevention Epicenters Program (2007) Improving the assessment of vancomycin-resistant enterococci by routine screening. J Infect Dis 195:339–346
Jahangiri S, Talebi M, Eslami G, Pourshafie MR (2010) Prevalence of virulence factors and antibiotic resistance in vancomycin-resistant Enterococcus faecium isolated from sewage and clinical samples in Iran. Indian J Med Microbiol 28:337–341
Kariyama R, Mitsuhata R, Chow JW, Clewell DB, Kumon H (2000) Simple and reliable Multiplex PCR assay for surveillance isolates of vancomycin resistant enterococci. J Clin Microbiol 38:3092–3095
Lund B, Agvald-Ohman C, Hultberg A, Edlund C (2002) Frequent transmission of enterococcal strains between mechanically ventilated patients treated at an intensive care unit. J Clin Microbiol 40:2084–2088
Pan SC, Wang JT, Chen YC, Chang YY, Chen ML, Chang SC (2012) Incidence of and risk factors for infection or colonization of vancomycin-resistant enterococci in patients in the intensive care unit. PLoS ONE 7:e47297
Pourshafie MR, Talebi M, Saifi M, Katouli M, Eshraghi S, Kühn I, Möllby R (2008) Clonal heterogeneity of clinical isolates of vancomycin-resistant Enterococcus faecium with unique vans. Trop Med Int Health 13:722–727
Rodríguez-Baño J, Ramírez E, Muniain MA, Santos J, Joyanes P, González F, García-Sánchez M, Martínez-Martínez L (2005) Colonization by high-level aminoglycoside-resistant enterococci in intensive care unit patients: epidemiology and clinical relevance. J Hosp Infect 60:353–359
Rossini FA, Fagnani R, Leichsenring ML, Dantas SR, Cardoso LG, Levy CE, Moretti ML, Trabasso P (2012) Successful prevention of the transmission of vancomycin-resistant enterococci in a Brazilian public teaching hospital. Rev Soc Bras Med Trop 45:184–188
Song JY, Cheong HJ, Jo YM, Choi WS, Noh JY, Heo JY, Kim WJ (2009) Vancomycin-resistant Enterococcus colonization before admission to the intensive care unit: a clinico-epidemiologic analysis. Am J Infect Control 37:734–740
Streit JM, Jones RN, Sader HS, Fritsche TR (2004) Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001). Int J Antimicrob Agents 24:111–118
Talebi M, Pourshafie MR, Katouli M, Möllby R (2008) Molecular structure and transferability of Tn1546-like elements in Enterococcus faecium isolates from clinical, sewage, and surface water samples in Iran. Appl Environ Microb 74:1350–1356
Talebi M, Rahimi F, Katouli M, Möllby R, Pourshafie MR (2008) Epidemiological link between wastewater and human vancomycin-resistant Enterococcus faecium isolates. Curr Microbiol 56:468–473
Toledano H, Schlesinger Y, Raveh D, Rudensky B, Attias D, Eidelman AI, Yinnon AM (2000) Prospective surveillance of vancomycin-resistant enterococci in a neonatal intensive care unit. Eur J Clin Microbiol Infect Dis 19:282–287
Zhanel GG, DeCorby M, Laing N, Weshnoweski B, Vashisht R, Tailor F, Nichol KA, Wierzbowski A, Baudry PJ, Karlowsky JA, Lagacé-Wiens P, Walkty A, McCracken M, Mulvey MR, Johnson J, Canadian Antimicrobial Resistance Alliance (CARA), Hoban DJ (2008) Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005–2006. Antimicrob Agents Chemother 52:1430–1437
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Talebi, M., Sadeghi, J. & Pourshafie, M.R. Molecular Characterization of Vancomycin-Resistant Enterococcus faecium Isolated from Intensive Care Units. Curr Microbiol 68, 615–620 (2014). https://doi.org/10.1007/s00284-013-0517-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00284-013-0517-0